THYROCARE TECHNOLOGIES
|
THYROCARE TECHNOLOGIES Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 13.42 | 12.47 | 33.28 | 21.14 | 16.75 |
| CEPS(Rs) | 22.00 | 19.47 | 39.70 | 27.13 | 22.77 |
| DPS(Rs) | - | - | 15.00 | 25.00 | 5.00 |
| Book NAV/Share(Rs) | 98.67 | 100.09 | 98.89 | 80.26 | 68.68 |
| Tax Rate(%) | 27.60 | 27.35 | 22.65 | 25.79 | 37.04 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 24.27 | 23.27 | 40.03 | 34.62 | 39.97 |
| EBIT Margin(%) | 17.75 | 17.74 | 39.22 | 31.00 | 32.76 |
| Pre Tax Margin(%) | 16.78 | 16.82 | 38.67 | 30.83 | 32.33 |
| PAT Margin (%) | 12.15 | 12.22 | 29.91 | 22.88 | 20.36 |
| Cash Profit Margin (%) | 20.37 | 19.57 | 35.66 | 29.00 | 27.70 |
| Performance Ratios | |||||
| ROA(%) | 10.00 | 8.00 | 25.38 | 22.43 | 18.84 |
| ROE(%) | 13.21 | 12.23 | 37.18 | 28.75 | 22.26 |
| ROCE(%) | 18.75 | 17.61 | 48.42 | 38.51 | 35.27 |
| Asset Turnover(x) | 0.82 | 0.65 | 0.85 | 0.98 | 0.93 |
| Sales/Fixed Asset(x) | 1.19 | 1.19 | 1.49 | 1.36 | 1.22 |
| Working Capital/Sales(x) | 3.04 | 2.69 | 2.87 | 4.71 | 11.02 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.84 | 0.84 | 0.67 | 0.73 | 0.82 |
| Receivable days | 41.03 | 61.79 | 42.73 | 22.50 | 11.96 |
| Inventory Days | 23.99 | 18.09 | 14.84 | 16.23 | 16.26 |
| Payable days | 70.18 | 45.30 | 44.68 | 52.19 | 45.78 |
| Valuation Parameters | |||||
| PER(x) | 44.13 | 34.45 | 23.25 | 42.72 | 29.58 |
| PCE(x) | 26.92 | 22.07 | 19.49 | 33.28 | 21.76 |
| Price/Book(x) | 6.00 | 4.29 | 7.82 | 11.25 | 7.22 |
| Yield(%) | - | - | 1.94 | 2.77 | 1.01 |
| EV/Net Sales(x) | 5.45 | 4.26 | 6.93 | 9.62 | 6.01 |
| EV/Core EBITDA(x) | 21.05 | 17.15 | 15.39 | 25.90 | 14.48 |
| EV/EBIT(x) | 30.71 | 24.04 | 17.66 | 31.03 | 18.35 |
| EV/CE(x) | 5.68 | 4.20 | 4.81 | 8.81 | 5.57 |
| M Cap / Sales | 5.48 | 4.32 | 6.95 | 9.65 | 6.03 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 8.58 | -10.56 | 19.05 | 13.90 | 7.78 |
| Core EBITDA Growth(%) | 13.12 | -50.58 | 44.25 | 1.91 | 9.78 |
| EBIT Growth(%) | 8.66 | -59.55 | 50.60 | 7.79 | 2.59 |
| PAT Growth(%) | 7.97 | -63.46 | 55.67 | 28.00 | 3.83 |
| EPS Growth(%) | 7.58 | -62.52 | 57.45 | 26.18 | 3.74 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.04 | - | - | - | 0.01 |
| Current Ratio(x) | 3.08 | 3.54 | 1.95 | 2.10 | 1.48 |
| Quick Ratio(x) | 2.55 | 3.18 | 1.84 | 1.86 | 1.23 |
| Interest Cover(x) | 18.36 | 19.34 | 71.94 | 176.25 | 76.90 |
| Total Debt/Mcap(x) | 0.01 | - | - | - | - |
Compare Financial Ratios of peers of THYROCARE TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| THYROCARE TECHNOLOGIES | ₹4,154.7 Cr | -4% | -14.3% | 21.6% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹99,731.0 Cr | -5.3% | -9.1% | 39.4% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹97,462.3 Cr | -2.1% | -7.1% | 8.7% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹47,430.2 Cr | -1.2% | -12.7% | 35.4% | Stock Analytics | |
| GLOBAL HEALTH | ₹27,908.9 Cr | -2.9% | -3.7% | -8.3% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹26,687.5 Cr | -1.6% | 2.5% | 0.4% | Stock Analytics | |
THYROCARE TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| THYROCARE TECHNOLOGIES | -4% |
-14.3% |
21.6% |
| SENSEX | 0.2% |
-2.2% |
7.7% |
You may also like the below Video Courses
